You searched for T cells - Page 16 of 41

In Depth 22 Dec 2022

10 biotech companies to watch in 2023

…disease (aGVHD), a condition that can arise when a patient is given a bone marrow transplant and transplanted immune cells attack the host body. To treat inflammation, Mesoblast sources a…

December 22, 2022 - 9 minutesmins - By Jonathan Smith

Startup Scout 28 Apr 2017

This Dutch Biotech Could Boost Gene Editing of Primary Cells

…to a transient cell manipulation since the protein-coding genes are not integrated into the genome, thus also lowering the risk of off-target effects. Images via shutterstock.com / TasfotoNL and hubrecht.eu…

April 28, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 30 Mar 2017

New Clues on How the Immune System Weakens with Age

…the immune system weakens with age. Their findings, which were published in the high-impact journal Science, show that immune cells in older tissues lack coordination and exhibit much more variability…

March 30, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 4 Feb 2025

Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology

…directly targeting tumor-associated antigens to activate the immune system, like CAR-T therapy, nor does it rely on ADCs that bind to membrane proteins on cancer cells. “G-dase E specifically targets…

February 4, 2025 - 6 minutesmins - By Jules Adam

Best in Biotech 24 Apr 2025

21 UK biotech companies you should know about

…therapeutic proteins that do not exist in nature. This approach allows for the development of proteins that can be tailored to specific functions, and it could also expand drug targets,…

April 24, 2025 - 27 minutesmins - By Willow Shah-Neville

cancer treatments immuno oncology companies

News and Trends 23 Nov 2020

SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’

…the two broad camps of traditional cancer treatments: those that kill cancer cells directly, and those that boost the immune system’s natural ability to destroy cancer cells. Instead, it is…

November 23, 2020 - 4 minutesmins - By Jonathan Smith

parkinsons disease treefrog therapeutics cell therapy

News and Trends 9 Jun 2020

French Manufacturing Plant Launches to Make Cell Therapy Cheap and Scalable

…this new facility, Treefrog Therapeutics aims to produce cell therapies using ten times less space and investment than the current manufacturing standard. The biotech will employ the facility to fuel…

June 9, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 23 Feb 2023

New promising targeted drug for a rare leukemia

…now shows that venetoclax does not appear to be effective against erythroid and megakaryoblastic leukemias, two rare subtypes of the disease that are difficult to treat. In these leukemia types,…

February 23, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 29 Oct 2024

GPCR therapies: Eight promising biotechs hacking the cell signaling pathway

…TT-702 works by making cancer more visible to the immune system so that the cells can be destroyed. It is currently in phase 1 trials to treat difficult-to-treat cancers such…

October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter

News and Trends 4 Sep 2024

2024: a year of breakthroughs for endometrial cancer?

…to attack tumor cells with specific receptors,” according to Cohen. “An example of this is the HER2 target for patients with tumor cells that highly express this receptor.” ADCs consist…

September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 24 May 2023

Biotech in Luxembourg: six companies that have made their name

…making them allergen-specific APCs. These modified APCs then interact with T cells to produce Treg cells, which, in turn suppress the harmful activity of effector Teff cells, balancing the immune…

May 24, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 30 Nov 2015

Cellectis’ CEO: “I’m just trying to be realistic, CAR-T is not THE miracle cure for Cancer”

…girl from the UK with multi-resistant leukemia. Let’s start directly with the latest news…People seemed over-enthusiastic about UCART19…even the New York Times wrote about it. What do you think? It’s…

November 30, 2015 - 5 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

10 biotech companies to watch in 2023

This Dutch Biotech Could Boost Gene Editing of Primary Cells

New Clues on How the Immune System Weakens with Age

Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology

21 UK biotech companies you should know about

SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’

French Manufacturing Plant Launches to Make Cell Therapy Cheap and Scalable

New promising targeted drug for a rare leukemia

GPCR therapies: Eight promising biotechs hacking the cell signaling pathway

2024: a year of breakthroughs for endometrial cancer?

Biotech in Luxembourg: six companies that have made their name

Cellectis’ CEO: “I’m just trying to be realistic, CAR-T is not THE miracle cure for Cancer”

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!